The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment

In this study, we investigated CD70 as a promising target for renal cell carcinoma (RCC) therapy and developed a potent chimeric antigen receptor T (CAR-T) cells for potential clinical testing. CD70, found to ...

Source: Journal of Translational Medicine - April 18, 2024 Category: Research Authors: Qinghui Xiong, Haiying Wang, Qiushuang Shen, Yan Wang, Xiujie Yuan, Guangyao Lin and Pengfei Jiang Tags: Research Source Type: research